HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vitamin D metabolism-related genetic variants, dietary protein intake and improvement of insulin resistance in a 2 year weight-loss trial: POUNDS Lost.

AbstractAIMS/HYPOTHESIS:
Vitamin D and related genetic variants are associated with obesity and insulin resistance. We aimed to examine whether vitamin D metabolism-related variants affect changes in body weight and insulin resistance in response to weight-loss diets varying in macronutrient content.
METHODS:
Three vitamin D metabolism-related variants, DHCR7 rs12785878, CYP2R1 rs10741657 and GC rs2282679, were genotyped in 732 overweight/obese participants from a 2 year weight-loss trial (POUNDS Lost). We assessed genotype effects on changes in body weight, fasting levels of glucose and insulin, and HOMA-IR at 6 months (up to 656 participants) and 2 years (up to 596 participants) in response to low-protein vs high-protein diets, and low-fat vs high-fat diets.
RESULTS:
We found significant interactions between DHCR7 rs12785878 and diets varying in protein, but not in fat, on changes in insulin and HOMA-IR at both 6 months (p for interaction <0.001) and 2 years (p for interaction ≤ 0.03). The T allele (vitamin-D-increasing allele) of DHCR7 rs12785878 was associated with greater decreases in insulin and HOMA-IR (p < 0.002) in response to high-protein diets, while there was no significant genotype effect on changes in these traits in the low-protein diet group. Generalised estimating equation analyses indicated significant genotype effects on trajectory of changes in insulin resistance over the 2 year intervention in response to high-protein diets (p < 0.001). We did not observe significant interaction between the other two variants and dietary protein or fat on changes in these traits.
CONCLUSIONS/INTERPRETATION:
Our data suggest that individuals carrying the T allele of DHCR7 rs12785878 might benefit more in improvement of insulin resistance than noncarriers by consuming high-protein weight-loss diets.
TRIAL REGISTRATION:
ClinicalTrials.gov NCT00072995.
AuthorsQibin Qi, Yan Zheng, Tao Huang, Jennifer Rood, George A Bray, Frank M Sacks, Lu Qi
JournalDiabetologia (Diabetologia) Vol. 58 Issue 12 Pg. 2791-9 (Dec 2015) ISSN: 1432-0428 [Electronic] Germany
PMID26416604 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural)
Chemical References
  • Blood Glucose
  • Dietary Proteins
  • Insulin
  • Vitamin D
  • Cytochrome P450 Family 2
  • CYP2R1 protein, human
  • Cholestanetriol 26-Monooxygenase
Topics
  • Adult
  • Aged
  • Blood Glucose (metabolism)
  • Body Weight
  • Cholestanetriol 26-Monooxygenase (genetics)
  • Cytochrome P450 Family 2
  • Diet, Protein-Restricted
  • Dietary Proteins (pharmacology)
  • Female
  • Genetic Variation
  • Genotype
  • Humans
  • Insulin (blood)
  • Insulin Resistance (genetics)
  • Male
  • Middle Aged
  • Obesity (diet therapy, genetics)
  • Overweight (diet therapy, genetics)
  • Polymorphism, Single Nucleotide
  • Treatment Outcome
  • Vitamin D (metabolism)
  • Weight Loss (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: